ArticleClinical kidney journal2026

Rituximab-based therapy in infection-associated severe crescentic proliferative glomerulonephritis with monoclonal immunoglobulin deposition.

Paola Richiez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.